GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Gross-Profit-to-Asset %

Star Lake Bioscience Co (SHSE:600866) Gross-Profit-to-Asset % : 17.63% (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Star Lake Bioscience Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥2,563 Mil. Star Lake Bioscience Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥14,536 Mil. Therefore, Star Lake Bioscience Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 17.63%.


Star Lake Bioscience Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Star Lake Bioscience Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Gross-Profit-to-Asset % Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.68 16.26 8.60 19.37 16.07

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.09 12.12 18.26 23.47 17.63

Competitive Comparison of Star Lake Bioscience Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Star Lake Bioscience Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Gross-Profit-to-Asset % falls into.



Star Lake Bioscience Co Gross-Profit-to-Asset % Calculation

Star Lake Bioscience Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=2440.74/( (15999.51+14384.586)/ 2 )
=2440.74/15192.048
=16.07 %

Star Lake Bioscience Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=2562.68/( (14384.586+14687.215)/ 2 )
=2562.68/14535.9005
=17.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Star Lake Bioscience Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines